Similar articles

• Deletion of chromosome 1p loci and microsatellite instability in neuroblastomas analyzed with short-tandem repeat polymorphisms.

  Martinsson T, Sjöberg RM, Hedborg F, Kogner P. Martinsson T, et al. Cancer Res. 1995 Dec 1;55(23):5681-6. Cancer Res. 1995. PMID: 7585654
• Deletion map of chromosome 9 and p16 (CDKN2A) gene alterations in neuroblastoma.

  Takita J, Hayashi Y, Kohno T, Yamaguchi N, Hanada R, Yamamoto K, Yokota J. Takita J, et al. Cancer Res. 1997 Mar 1;57(5):907-12. Cancer Res. 1997. PMID: 9041193
• Allelotype of neuroblastoma.

  Takita J, Hayashi Y, Kohno T, Shiseki M, Yamaguchi N, Hanada R, Yamamoto K, Yokota J. Takita J, et al. Oncogene. 1995 Nov 2;11(9):1829-34. Oncogene. 1995. PMID: 7478611
• Is there a neuroblastoma anti-oncogene?

  Schwab M. Schwab M. Prog Clin Biol Res. 1991;366:1-9. Prog Clin Biol Res. 1991. PMID: 2068129 Review. No abstract available.
• Neuroblastoma and the clinical significance of N-myc oncogene amplification.

  Phillips WS, Stafford PW, Duvol-Arnold B, Ghosh BC. Phillips WS, et al. Surg Gynecol Obstet. 1991 Jan;172(1):73-80. Surg Gynecol Obstet. 1991. PMID: 1985349 Review. No abstract available.